{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T15:51:50Z","timestamp":1775922710261,"version":"3.50.1"},"reference-count":61,"publisher":"Wiley","issue":"S4","license":[{"start":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:00:00Z","timestamp":1299801600000},"content-version":"vor","delay-in-days":6598,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[1993,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gestational trophoblastic disease is a term that describes a group of tumors that share several characteristics as follows: (1) they arise in fetal chorion, (2) they produce human chorionic gonadotropin (hCG), and (3) they respond extremely well to chemotherapy. Although rare, they have received a disproportionate amount of attention because they were the first metastatic solid tumor to be cured using chemotherapy. Also, hCG was the first reliable tumor marker. Finally, because they arise in fetal tissue, they have the potential for a strong immune response against paternal antigens in the tumor. This potential for immunologic rejection was thought initially to explain the success of chemotherapy in this disease. The early detection of gestational trophoblastic disease is successful in patients who have had a hydatidiform mole as the pregnancy event that begins the process but unsuccessful in the early detection of the development of choriocarcinoma after a normal term delivery, abortion (spontaneous or elective), or ectopic pregnancy. Surveillance after evacuation of a molar pregnancy (whether complete or a partial mole) consists of regular evaluation of hCG production and the detection of metastatic disease. However, the development of gestational choriocarcinoma after term pregnancy or an abortion (no molar tissue can develop as a consequence of these pregnancies) is detectable only by signs or symptoms of metastatic disease in any of the many organs to which this tissue can spread. Unlike most staging classifications in gynecologic cancers, which are based on histologic findings and tumor location, the classification used in gestational trophoblastic disease stresses other features that are more useful for treatment selection. Both the National Institutes of Health and the World Health Organization classifications emphasize the importance of recognizing factors that predict the likelihood of a tumor responding to chemotherapy. Currently available treatment can cure all patients except those who are in the very high\u2010risk group, which usually is characterized by metastasis to the brain or liver or a history of prior chemotherapy. Even in this category, approximately 80% of patients are curable.<\/jats:p>","DOI":"10.1002\/cncr.2820710430","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T09:31:27Z","timestamp":1299835887000},"page":"1639-1647","source":"Crossref","is-referenced-by-count":43,"title":["Diagnosis and management of gestational trophoblastic disease"],"prefix":"10.1002","volume":"71","author":[{"suffix":"Jr.","given":"John L.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-93-22757"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(61)90283-6"},{"key":"e_1_2_1_4_2","volume-title":"Cancer facts and figures: 1992","author":"American Cancer Society","year":"1992"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91393-3"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)33244-6"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/268633a0"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(78)90829-3"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(78)90792-5"},{"key":"e_1_2_1_10_2","first-page":"49","article-title":"The early history of choriocarcinoma","volume":"16","author":"Ober WB","year":"1961","journal-title":"J Hist Med"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91834-2"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92167-6"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1959.tb49199.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)35583-1"},{"key":"e_1_2_1_15_2","first-page":"73","article-title":"Choriocarcinoma: a general review, with analysis of 516 cases","volume":"49","author":"Park WW","year":"1950","journal-title":"Arch Pathol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1971.tb34943.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197609)38:3<1214::AID-CNCR2820380323>3.0.CO;2-J"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198101000-00010"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(81)90153-0"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-198403010-00009"},{"key":"e_1_2_1_21_2","first-page":"854","article-title":"Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center","volume":"71","author":"Finkler NJ","year":"1988","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)35198-5"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(68)90570-X"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1972.03200020029007"},{"key":"e_1_2_1_25_2","first-page":"1","article-title":"Hydatidiform mole: diagnosis, management, and long\u2010term follow\u2010up of 347 patients","volume":"45","author":"Curry SL","year":"1975","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(77)90562-2"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197811000-00006"},{"key":"e_1_2_1_28_2","first-page":"478","article-title":"Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy","volume":"58","author":"Schlaerth JB","year":"1981","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_29_2","first-page":"78","article-title":"Hydatidiform mole and gestational trophoblastic disease in southern Connecticut","volume":"59","author":"Kohorn EI","year":"1982","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1973.tb15962.x"},{"key":"e_1_2_1_31_2","volume-title":"International Federation of Gynecology and Obstetrics","year":"1985"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(73)90389-X"},{"key":"e_1_2_1_33_2","first-page":"75","article-title":"Choriocarcinoma Task Force: transactions of the Annual Meeting of the Society of Alumni of the Sloane Hospital for Women","volume":"15","author":"Lewis JL","year":"1969","journal-title":"Bull Sloane Hosp Women"},{"key":"e_1_2_1_34_2","first-page":"565","article-title":"Treatment of metastatic trophoblastic disease with poor prognosis","volume":"55","author":"Surwit EA","year":"1980","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_35_2","volume-title":"World Health Organization Scientific Group on Gestational Trophoblastic Diseases","year":"1983"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90106-6"},{"key":"e_1_2_1_38_2","first-page":"1015","article-title":"Actinomycin D in the treatment of methotrexate\u2010resistant trophoblastic disease in women","volume":"22","author":"Ross GT","year":"1962","journal-title":"Cancer Res"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1960.03030100059013"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)33879-2"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90088-5"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1979.289"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(80)90359-X"},{"key":"e_1_2_1_44_2","first-page":"239","article-title":"New chemotherapeutic agents in the management of gestational trophoblastic disease","volume":"9","author":"Newlands ES","year":"1982","journal-title":"Semin Oncol"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(86)90007-7"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861001)58:7<1407::AID-CNCR2820580704>3.0.CO;2-2"},{"key":"e_1_2_1_47_2","first-page":"189","article-title":"Vinblastine, cisplatin, and bleomycin as salvage therapy for refractory high\u2010risk metastatic gestational trophoblastic disease","volume":"34","author":"DuBeschter B","year":"1989","journal-title":"J Reprod Med"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90039-A"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.169.3952.1326"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb10369.x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197602)37:2 <1043::AID-CNCR2820370809>3.0.CO;2-N"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303033080901"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(77)90400-8"},{"key":"e_1_2_1_54_2","first-page":"276","article-title":"Human chorionic gonadotropin as a tumor marker","volume":"4","author":"Vaitukaitis JL","year":"1974","journal-title":"Ann Clin Lab Science"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(72)90553-4"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-88-4-1045"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4698-5_8"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(88)90809-5"},{"key":"e_1_2_1_59_2","first-page":"1356","article-title":"Urinary human chorionic gonadotropin free beta sub\u2010unit and beta core fragment: a new marker of gynecologic cancers","volume":"48","author":"Cole LA","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_1_60_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0002-9378(76)90798-5","article-title":"Limitation of the specific serum radioimmunoassay for human chorionic gonadotropin in the management of trophoblastic neoplasms","volume":"125","author":"Shreiber JR","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196403262701306"},{"key":"e_1_2_1_62_2","first-page":"795","volume-title":"Principles and practice of gynecologic oncology","author":"Soper JT","year":"1992"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.2820710430","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.2820710430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:25:29Z","timestamp":1760297129000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.2820710430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2,15]]},"references-count":61,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[1993,2,15]]}},"alternative-id":["10.1002\/cncr.2820710430"],"URL":"https:\/\/doi.org\/10.1002\/cncr.2820710430","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2,15]]}}}